Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mangiameli

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1979
Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial. Second of two partsL Barbara, E Belsasso, G Bianchi Porro, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1979
Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial, First of two partsL Barbara, E Belsasso, G Bianchi Porro, et al.
Oncology|July 16, 2005
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II studyS Palmeri, M Vaglica, S Spada, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1979
Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial. Second of two partsL Barbara, E Belsasso, G Bianchi Porro, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1979
Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial, First of two partsL Barbara, E Belsasso, G Bianchi Porro, et al.
Oncology|July 16, 2005
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II studyS Palmeri, M Vaglica, S Spada, et al.
Pageof 5